CDC Website CDC Website

To Join the NPIN community or

Home » Search » Publication

Search Results

COVID-19: General Information | Testing | Vaccines |

Contact Organizations directly about changes to services or hours

Search Menu

You've Selected

Reset Filters

Disease

Topic

Format

Population

Language

Results 1 - 2 of 2

Generic Programmatic and Clinical Guide for the Introduction of new drugs and Shorter Regimens for the Treatment of Multi/Extensively Drug-Resistant Tuberculosis

Generic programmatic and clinical guide for the introduction of new drugs and shorter regimens for the treatment of Multi/Extensively Drug-Resistant Tuberculosis-Monograph
By KNCV Tuberculosis Foundation/US Agency for International Development
2016 - English
This document describes the steps necessary to implement the shorter regimen and the new drugs for drug-resistant TB treatment, including diagnosis and bacterial confirmation of drug resistance, treatment regimen design, monitoring of treatment efficacy and safety, and programmatic evaluation.

US Preventive Services Task Force Recommendation Statement: Screening for Latent Tuberculosis Infection (LTBI) in Adults

U.S. Preventive Services Task Force Recommendation Statement: Screening for Latent Tuberculosis Infection (LTBI) in Adults, Centers for Disease Control and Prevention, Division of Tuberculosis Elimination, September 2016-Slideset
By Centers for Disease Control and Prevention
2016 - English
Key messages of this presentation include 1) eliminating TB in the U.S. requires expanding testing and treatment of LTBI; 2) the CDC and USPSTF recommend testing populations that are at increased risk for TB infection; and 3) clinicians, health care agencies, and community organizations, especially...
CONTACT CDC-INFO
Have questions? We have answers. 1-800-CDC-INFO (800-232-4636) TTY: 888-232-6348
CDC INFORMATION
CONNECT WITH CDC